Development and Clinical Validation of Key Technologies for Non-invasive Breath Metabolic Fingerprinting for Large-scale Population Lipid Screening

Starting soon

Conditions studied: Hyperlipidemia

In brief

This study collects exhaled breath condensate samples from healthy populations and hyperlipidemic populations, analyzes the characteristics of the exhaled metabolic lipid profile for early identification of people with abnormal blood lipids, verifies the feasibility and accuracy of a new gas detection method for screening abnormal blood lipids, and explores a simple, fast, and non-invasive method for screening abnormal blood lipids.

Key facts

Study ID

NCT07546162

Run by

Beijing Anzhen Hospital

People needed

280

Starts

2026-04-02

Expected to finish

2026-05-31

Last updated by the study team

2026-04-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age ≥ 18 years
• Voluntarily sign the informed consent form

You may not qualify if…

• Patients with lung cancer, asthma, chronic obstructive pulmonary disease, cystic fibrosis, or acute respiratory distress syndrome
• Women during pregnancy or breastfeeding
• Patients with chronic kidney disease (GFR <60 ml/min) or liver cirrhosis
• Individuals unable to cooperate in collecting exhaled breath samples

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.